Administrative Core

行政核心

基本信息

  • 批准号:
    10364709
  • 负责人:
  • 金额:
    $ 32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-03-15 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

CETR Administrative Core ABSTRACT The key role of the Administrative Core of the University of Maryland, Baltimore's Center of Excellence for Translational Research (CETR) is to organize, manage comprehensively, facilitate, evaluate and supervise investigators and institutions to ensure highly productive research efforts. A key mission of this Administrative Core is to maintain a stable centralized, yet flexible and responsive, infrastructure to promote and harmonize the research and product development activities towards the prevention of multidrug-resistant bacterial diseases. Responsibilities of the CETR Administrative Core will include, but are not limited to: 1) facilitating communications amongst the Research Projects and the Principal Investigator; 2) scheduling group meetings and conferences; 3) management of program-related travel (including travel for the annual meeting); 4) annual reporting; 5) organizing presentations and publication of data; 6) creation and implementation of administrative and leadership mechanisms to foster effective interactions among investigators; 7) development and implementation of a CETR evaluation plan; 8) identifying and resolving problems and unexpected outcomes; 9) resource sharing and transmission of information and materials; 10) facilitating the timely release of research findings and sharing of data per the NIH data sharing plan; 11) allocating and reallocating resources to meet program goals; 12) tracking and prioritizing fiscal and other resources; and 13) compliance with federal and NIH regulations. The CETR Administrative Core will be led by its Principal Investigator and Director, Myron M. Levine, M.D., D.T.P.H., who will oversee coordination efforts among the five Research Projects and will work to foster a strong collaborative environment. He will be responsible for monitoring all research and for overseeing the implementation of each project's Product Development Strategy. He will share his experience in vaccine product development and will provide guidance to each of the projects in this area. Additionally, a Scientific Advisory Committee will be composed of three parts; the Executive Committee, Regulatory Experts, and the External Advisory Board. Together they will interact with and support the Principal Investigator in the overall management and evaluation of all research and product development activities. Over the past five years, the same administrative team at the Center for Vaccine Development at the University of Maryland, Baltimore has successfully managed the previous U19 CETR award (Dr. Levine, PI). In addition, the administrative team has served as the lead for many other multi-site, multi-project grants and cooperative agreements. The breadth and depth of experience over such a diverse group of grants and contracts is indicative of the proficiencies of this highly competent Administrative Core, which is poised to manage the CETR.
Cetr行政核心摘要 马里兰州大学行政核心的关键角色,巴尔的摩卓越中心 转化研究(CERT)将全面组织,管理,促进,评估和监督 调查人员和机构确保高生产力的研究工作。此行政管理的关键任务 核心是维持稳定的集中式,灵活且响应迅速的基础架构,以促进和协调 用于预防多药耐药细菌的研究和产品开发活动 疾病。 Cetr行政核心的责任将包括但不限于:1)促进 研究项目和主要研究人员之间的沟通; 2)调度小组会议 和会议; 3)与计划相关的旅行管理(包括年度会议的旅行); 4)年度 报告; 5)组织和发布数据; 6)创建和实施管理 和领导机制,以促进研究人员之间有效互动; 7)发展和 实施CORT的评估计划; 8)确定和解决问题和意外结果; 9) 资源共享和传输信息和材料; 10)促进及时释放研究 根据NIH数据共享计划的发现和数据共享; 11)分配和重新分配资源以满足 计划目标; 12)跟踪和优先考虑财政和其他资源; 13)遵守联邦和 NIH法规。 CERTR行政核心将由其首席调查员兼董事Myron M. Levine领导 M.D.,D.T.P.H.,他将在五个研究项目中监督协调工作,并将努力 一个强大的协作环境。他将负责监视所有研究并监督 实施每个项目的产品开发策略。他将分享他在疫苗方面的经验 产品开发并将为该领域的每个项目提供指导。另外,科学 咨询委员会将由三个部分组成;执行委员会,监管专家和 外部顾问委员会。他们将共同互动并支持总体研究者 所有研究和产品开发活动的管理和评估。 在过去的五年中,疫苗开发中心的同一行政团队 马里兰州,巴尔的摩大学已成功管理了以前的U19 CERTR奖(Levine博士,PI)。在 此外,行政团队还担任许多其他多站点,多项目的赠款和 合作协议。如此多样化的赠款和经验的广度和深度 合同表明这种高度称职的行政核心的熟练程度,该核心有望 管理CTR。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Myron Max Levine其他文献

Myron Max Levine的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Myron Max Levine', 18)}}的其他基金

Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
主动疫苗接种和被动抗体策略预防多重耐药细菌病原体引起的疾病
  • 批准号:
    9893801
  • 财政年份:
    2019
  • 资助金额:
    $ 32万
  • 项目类别:
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
主动疫苗接种和被动抗体策略预防多重耐药细菌病原体引起的疾病
  • 批准号:
    10584474
  • 财政年份:
    2019
  • 资助金额:
    $ 32万
  • 项目类别:
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
主动疫苗接种和被动抗体策略预防多重耐药细菌病原体引起的疾病
  • 批准号:
    10364708
  • 财政年份:
    2019
  • 资助金额:
    $ 32万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10584475
  • 财政年份:
    2019
  • 资助金额:
    $ 32万
  • 项目类别:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
控制新发肠道感染的免疫预防策略
  • 批准号:
    9232995
  • 财政年份:
    2014
  • 资助金额:
    $ 32万
  • 项目类别:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
控制新发肠道感染的免疫预防策略
  • 批准号:
    9447098
  • 财政年份:
    2014
  • 资助金额:
    $ 32万
  • 项目类别:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
控制新发肠道感染的免疫预防策略
  • 批准号:
    8803292
  • 财政年份:
    2014
  • 资助金额:
    $ 32万
  • 项目类别:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
控制新发肠道感染的免疫预防策略
  • 批准号:
    8642251
  • 财政年份:
    2014
  • 资助金额:
    $ 32万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8233367
  • 财政年份:
    2011
  • 资助金额:
    $ 32万
  • 项目类别:
University of Maryland Development Research Program
马里兰大学发展研究计划
  • 批准号:
    8233368
  • 财政年份:
    2011
  • 资助金额:
    $ 32万
  • 项目类别:

相似海外基金

Therapeutic Agents Targeting Cryptococcal Infections
针对隐球菌感染的治疗药物
  • 批准号:
    10697960
  • 财政年份:
    2023
  • 资助金额:
    $ 32万
  • 项目类别:
Selective proteasome inhibitors for trichomoniasis
滴虫病的选择性蛋白酶体抑制剂
  • 批准号:
    9806764
  • 财政年份:
    2019
  • 资助金额:
    $ 32万
  • 项目类别:
Host defense against Shigella flexneri
宿主对福氏志贺氏菌的防御
  • 批准号:
    10601092
  • 财政年份:
    2019
  • 资助金额:
    $ 32万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10584475
  • 财政年份:
    2019
  • 资助金额:
    $ 32万
  • 项目类别:
EF-Tu binding Tetrazoles targeting MDR Neisseria gonorrhoeae
EF-Tu 结合四唑靶向耐多药淋病奈瑟菌
  • 批准号:
    9753119
  • 财政年份:
    2018
  • 资助金额:
    $ 32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了